Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis
Patients with rheumatoid arthritis (RA) have increased cardiovascular mortality. TNF-α is a
critical mediator of inflammation and metabolic response in patients with RA. Increased …
critical mediator of inflammation and metabolic response in patients with RA. Increased …
Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection
Objective To compare the prevalence of abnormal Pap smears in patients with systemic
lupus erythematosus (SLE) with that in a large group of healthy controls, and to determine …
lupus erythematosus (SLE) with that in a large group of healthy controls, and to determine …
Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong
Objective : To determine the risk factors associated with and to describe the clinical course
of tuberculosis (TB) in patients with systemic lupus erythematosus (SLE). Methods : Clinical …
of tuberculosis (TB) in patients with systemic lupus erythematosus (SLE). Methods : Clinical …
Subclinical carotid atherosclerosis in patients with psoriatic arthritis
…, EK Li, B Tomlinson, TTW Chu, M Li… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To examine the prevalence of subclinical atherosclerosis in patients with psoriatic
arthritis (PsA) compared with healthy controls, and to identify clinical and biologic markers …
arthritis (PsA) compared with healthy controls, and to identify clinical and biologic markers …
Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity
Introduction B lymphocyte chemoattractant (BLC/CXCL13), a CXC chemokine, is involved in
B1 and B2 cell trafficking for the activation of autoreactive T helper (Th) cells and …
B1 and B2 cell trafficking for the activation of autoreactive T helper (Th) cells and …
Leflunomide in the treatment of rheumatoid arthritis
Background: Current drug therapies for rheumatoid arthritis (RA), including nonsteroidal anti-inflammatory
drugs and disease-modifying antirheumatic drugs, help control inflammation …
drugs and disease-modifying antirheumatic drugs, help control inflammation …
[HTML][HTML] Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis
Introduction Interleukin (IL)-27 is a novel member of the IL-6/IL-12 family cytokines that are
produced early by antigen-presenting cells in T helper (Th)1-mediated inflammation. Elevated …
produced early by antigen-presenting cells in T helper (Th)1-mediated inflammation. Elevated …
Cost‐of‐illness studies in systemic lupus erythematosus: A systematic review
Objective To summarize the state of knowledge regarding the economic burden of systemic
lupus erythematosus (SLE) and to evaluate the quality of cost‐of‐illness (COI) studies …
lupus erythematosus (SLE) and to evaluate the quality of cost‐of‐illness (COI) studies …
CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis
Objective. To assess whether serum levels of CC and CXC chemokines correlate with disease
activity in patients with rheumatoid arthritis (RA), and to determine whether these effects …
activity in patients with rheumatoid arthritis (RA), and to determine whether these effects …
The impact of flare on disease costs of patients with systemic lupus erythematosus
Objective To evaluate both direct and indirect costs of systemic lupus erythematosus (SLE)
patients with and without flares from a societal perspective, and to investigate the impact of …
patients with and without flares from a societal perspective, and to investigate the impact of …